NO931536L - Fremgangsmaater og sammensetninger for undertrykkelse av allograftforkastelse hos pattedyr - Google Patents
Fremgangsmaater og sammensetninger for undertrykkelse av allograftforkastelse hos pattedyrInfo
- Publication number
- NO931536L NO931536L NO93931536A NO931536A NO931536L NO 931536 L NO931536 L NO 931536L NO 93931536 A NO93931536 A NO 93931536A NO 931536 A NO931536 A NO 931536A NO 931536 L NO931536 L NO 931536L
- Authority
- NO
- Norway
- Prior art keywords
- allograft
- rejection
- mammals
- allographic
- suppression
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Abstract
Fremgangsmåter for å undertrykke allograftforkastelser i pattedyr omfatter administrering til et pattedyr somiskal gjennomgå eller som har gjennomgått allograftkirurgi, et middel valgt fra gruppen som består av splenisk vev fra en allograftglver, splenlske ekstrakter, dyrkede lymfocytter fra en allograftgiver, ekstrakter fra nevnte dyrkede lymfocytter, MHC- antlgener, transplantasjonsforkastelsesundertrykkende fragmenter og analoger av MHC-antlgener l en oral eller aerosolform. Det ble også beskrevet farmasøytiske formuleringer og doseringsformer for anvendelse i nevnte fremgangsmåter.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60782690A | 1990-10-31 | 1990-10-31 | |
PCT/US1991/008143 WO1992007581A1 (en) | 1990-10-31 | 1991-10-31 | Methods and compositions for suppressing allograft rejection in mammals |
Publications (2)
Publication Number | Publication Date |
---|---|
NO931536L true NO931536L (no) | 1993-04-27 |
NO931536D0 NO931536D0 (no) | 1993-04-27 |
Family
ID=24433875
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO931536A NO931536D0 (no) | 1990-10-31 | 1993-04-27 | Fremgangsmaater og sammensetninger for undertrykkelse av allograftforkastelse hos pattedyr |
Country Status (11)
Country | Link |
---|---|
US (2) | US5681556A (no) |
EP (1) | EP0555413A4 (no) |
JP (1) | JP2547162B2 (no) |
KR (1) | KR0161235B1 (no) |
AU (1) | AU662500B2 (no) |
BR (1) | BR9107055A (no) |
CA (1) | CA2093513C (no) |
HU (1) | HUT63957A (no) |
IL (1) | IL99864A (no) |
NO (1) | NO931536D0 (no) |
WO (1) | WO1992007581A1 (no) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5571500A (en) * | 1987-06-24 | 1996-11-05 | Autoimmune, Inc. | Treatment of autoimmune diseases through administration by inhalation of autoantigens |
US5571499A (en) * | 1987-06-24 | 1996-11-05 | Autoimmune, Inc. | Treatment of autoimmune diseases by aerosol administration of autoantigens |
US5641474A (en) * | 1987-06-24 | 1997-06-24 | Autoimmune, Inc. | Prevention of autoimmune diseases by aerosol administration of autoantigens |
US5645820A (en) * | 1987-06-24 | 1997-07-08 | Autoimmune, Inc. | Treatment of autoimmune diseases by aerosol administration of autoantigens |
IL99699A (en) | 1990-10-10 | 2002-04-21 | Autoimmune Inc | Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes |
CA2081028C (en) * | 1991-03-12 | 1999-12-14 | Barbara P. Wallner | Cd2 binding domain of lymphocyte function associated antigen 3 |
MX9203138A (es) * | 1991-03-12 | 1992-09-01 | Biogen Inc | Dominio de enlace cd2-de antigeno 3 (lfa-3) asociado con funcion linfositos. |
US6764681B2 (en) | 1991-10-07 | 2004-07-20 | Biogen, Inc. | Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction |
GB9319429D0 (en) | 1993-09-21 | 1993-11-03 | London Health Ass | Methods and products for controlling immune responses in mammals |
JPH09508277A (ja) * | 1994-01-27 | 1997-08-26 | ブレサゲン リミテッド | ヒト異種移植における超急性拒絶の管理のための物質及び方法 |
US5849991A (en) | 1994-01-27 | 1998-12-15 | Bresatch Limited | Mice homozygous for an inactivated α 1,3-galactosyl transferase gene |
JPH08239324A (ja) * | 1995-03-03 | 1996-09-17 | Fusanori Hamashima | 免疫抑制剤 |
US20020155117A1 (en) * | 1996-04-04 | 2002-10-24 | Nicole Suciu-Foca | Method for detecting organ allograft rejection and uses thereof |
WO1998037917A1 (en) * | 1997-02-28 | 1998-09-03 | Enzo Therapeutics, Inc., A Fully Owned Subsidiary Of Enzo Biochem, Inc. | Novel processes implementing selective immune down regulation (sidr) |
US7097845B2 (en) | 1997-04-23 | 2006-08-29 | Jacob Sten Petersen | Combinations of antigen and mucosal binding component for inducing specific immunological tolerance |
US6685936B2 (en) * | 1999-10-12 | 2004-02-03 | Osiris Therapeutics, Inc. | Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation |
US20020012667A1 (en) * | 2000-05-16 | 2002-01-31 | Mcmichael John | Method for preventing allograft rejection |
AU2001264813B2 (en) | 2000-05-24 | 2005-12-08 | The United States Of America, As Represented By Secretary Of The Department Of Health And Human Services | Methods for preventing strokes by inducing tolerance to e-selectin |
US20030170258A1 (en) * | 2001-05-09 | 2003-09-11 | Enzo Therapeutics, Inc. | Novel processes implementing selective immune down regulation (SIDR) |
AU2002320352A1 (en) | 2001-07-24 | 2003-02-17 | Biogen Idec Ma Inc. | Methods for treating or preventing sclerotic disorders using cd2-binding agents |
CN100415227C (zh) * | 2001-10-25 | 2008-09-03 | 阿特罗吉尼克斯公司 | 化合物在制备用于治疗移植排斥的药物中的应用 |
EP1750747A1 (en) | 2004-05-07 | 2007-02-14 | Astellas US LLC | Soluble lfa-3 polypeptide for treating viral disorders |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5899419A (ja) * | 1981-12-07 | 1983-06-13 | Green Cross Corp:The | 免疫抑制剤 |
AU1980183A (en) * | 1982-10-01 | 1984-04-05 | Bio-Com Inc. | Compositions for inducing immunosuppression or immunoregulation of the immune response to an antigen |
US4635627A (en) * | 1984-09-13 | 1987-01-13 | Riker Laboratories, Inc. | Apparatus and method |
US5130297A (en) * | 1988-06-23 | 1992-07-14 | Anergen, Inc. | Conjugates useful in ameliorating autoimmunity MHC-II-peptide |
US5011037A (en) * | 1989-11-30 | 1991-04-30 | Adolph Coors Company | Container end member |
RU2054180C1 (ru) * | 1991-08-21 | 1996-02-10 | Жирнов Олег Петрович (н/п) | Способ лечения вирусных респираторных инфекций |
-
1991
- 1991-10-27 IL IL9986491A patent/IL99864A/xx not_active IP Right Cessation
- 1991-10-31 EP EP9292902860A patent/EP0555413A4/en not_active Withdrawn
- 1991-10-31 KR KR1019930701248A patent/KR0161235B1/ko not_active IP Right Cessation
- 1991-10-31 CA CA002093513A patent/CA2093513C/en not_active Expired - Fee Related
- 1991-10-31 HU HU931252A patent/HUT63957A/hu unknown
- 1991-10-31 JP JP4500909A patent/JP2547162B2/ja not_active Expired - Lifetime
- 1991-10-31 BR BR919107055A patent/BR9107055A/pt not_active Application Discontinuation
- 1991-10-31 WO PCT/US1991/008143 patent/WO1992007581A1/en not_active Application Discontinuation
- 1991-10-31 AU AU89426/91A patent/AU662500B2/en not_active Ceased
-
1993
- 1993-04-27 NO NO931536A patent/NO931536D0/no not_active Application Discontinuation
- 1993-11-29 US US08/159,044 patent/US5681556A/en not_active Expired - Fee Related
-
1995
- 1995-06-05 US US08/461,661 patent/US5788968A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
KR930701969A (ko) | 1993-09-08 |
US5681556A (en) | 1997-10-28 |
AU662500B2 (en) | 1995-09-07 |
HUT63957A (en) | 1993-11-29 |
JP2547162B2 (ja) | 1996-10-23 |
NO931536D0 (no) | 1993-04-27 |
HU9301252D0 (en) | 1993-07-28 |
AU8942691A (en) | 1992-05-26 |
IL99864A0 (en) | 1992-08-18 |
BR9107055A (pt) | 1993-09-21 |
KR0161235B1 (ko) | 1998-12-01 |
EP0555413A1 (en) | 1993-08-18 |
CA2093513A1 (en) | 1992-05-01 |
US5788968A (en) | 1998-08-04 |
WO1992007581A1 (en) | 1992-05-14 |
JPH05508663A (ja) | 1993-12-02 |
CA2093513C (en) | 1999-03-23 |
EP0555413A4 (en) | 1994-12-07 |
IL99864A (en) | 2000-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO931536L (no) | Fremgangsmaater og sammensetninger for undertrykkelse av allograftforkastelse hos pattedyr | |
Smith et al. | The adoptive transfer of pregnancy-induced unresponsiveness to male skin grafts with thymus-dependent cells. | |
AR059693A2 (es) | Una composicion farmaceutica de micofenolato y su uso | |
DE69620877D1 (de) | Arzneimittelformulierungen für il-12 | |
WO2017179840A1 (ko) | 트롬빈 처리 줄기세포에서 유래된 엑소좀을 포함하는 만성폐질환 치료용 조성물 | |
NO965207L (no) | Sammensetning for indusering av mukosal immunrespons | |
BR9306345A (pt) | Métodos para suprimir a habilidade de células-t de um mamífero de proliferar e para suprimir resposta imune composições para uso na supressão da capacidade de células-t de proliferarem e na supressão de resposta imune | |
DE60202278D1 (de) | Aktivierung natürlicher killerzellen durch adenosin-a3-rezeptoragonisten | |
Yazici et al. | A new rat model of maxilla allotransplantation | |
DE68917738T2 (de) | Therapeutisch aktive substituierte Benzimidazole und Verfahren zu ihrer Herstellung. | |
Ercan et al. | The effects of cold-restraint stress on urinary bladder wall compared with interstitial cystitis morphology | |
DE69129459D1 (de) | Immunosuppressive zusammensetzungen | |
MX9301675A (es) | Composiciones que contienen peptidos para inducir tolerancia de las celulas t a un antigeno. | |
YU47338B (sh) | Novo jedinjenje 4-fluoro-2-// (4-metoksi-2-piridinil)metil-/sulfinil/- 1h-benzimidazol i postupak za njegovo dobijanje | |
DE69003998D1 (de) | N-Phenylamide, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel. | |
HUP9800829A2 (hu) | Kollagén alapú módszerek és készítmények az immunrendszer által közvetített betegségek kezelésére | |
Kawahara et al. | Prolongation of heterotopic cardiac allografts in rats by cyclosporin A | |
Matt et al. | Decoupling of exocytotic membrane fusion from protein discharge in Paramecium cells | |
Campbell et al. | T-cell control of IgA production. I. Distribution, activation conditions and culture of isotype-specific regulatory helper cells. | |
Andres et al. | Structural observations on epithelioid and giant cells in experimental autoimmune tubulointerstitial nephritis in guinea pigs. | |
ES2126923T3 (es) | 8-fluoro-antraciclinas, procedimientos para su preparacion y composiciones farmaceuticas que las contienen. | |
DK630088A (da) | Azelastinembonat, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater med indhold af denne forbindelse som aktivt middel | |
Kamel et al. | Failure of in vitro-expanded hyperimmune cytotoxic T lymphocytes to affect survival of mouse embryos in vivo | |
MYERS et al. | ON THE LACK OF ANY EFFECT OF GRAVITY ON THE SURVIVAL OF TUBED FLAPS: An Experimental Study in Rabbits and Pigs | |
Silvers et al. | The Influence of Removing Passenger Cells on the Fate of Skin and Parathyroid Allografts: Evidence for Major Histocompatibility Complex Restriction in Transplantation Immunity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |